Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Hardas

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Journal of the American Veterinary Medical Association|October 5, 2021
Pathology in PracticeAlexander Hardas, Simon L Priestnall, Rachel Pittaway, et al.
Cancers|July 30, 2020
The Tumor Suppressor CYLD Inhibits Mammary Epithelial to Mesenchymal Transition by the Coordinated Inhibition of YAP/TAZ and TGF SignalingAthanasios Pseftogas, Konstantinos Xanthopoulos, Theofilos Poutahidis, et al.
Oncology Letters|February 6, 2018
Effects of Wnt-1 blockade in DEN-induced hepatocellular adenomas of miceArgyrios Sklavos, Theofilos Poutahidis, Alexander Giakoustidis, et al.
Journal of Cancer|March 28, 2018
Targeting hepatocarcinogenesis model in C56BL6 mice with pan-aurora kinase inhibitor DanusertibPaschalis Gavriilidis, Theofilos Poutahidis, Alexander Giakoustidis, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Journal of the American Veterinary Medical Association|October 5, 2021
Pathology in PracticeAlexander Hardas, Simon L Priestnall, Rachel Pittaway, et al.
Cancers|July 30, 2020
The Tumor Suppressor CYLD Inhibits Mammary Epithelial to Mesenchymal Transition by the Coordinated Inhibition of YAP/TAZ and TGF SignalingAthanasios Pseftogas, Konstantinos Xanthopoulos, Theofilos Poutahidis, et al.
Oncology Letters|February 6, 2018
Effects of Wnt-1 blockade in DEN-induced hepatocellular adenomas of miceArgyrios Sklavos, Theofilos Poutahidis, Alexander Giakoustidis, et al.
Journal of Cancer|March 28, 2018
Targeting hepatocarcinogenesis model in C56BL6 mice with pan-aurora kinase inhibitor DanusertibPaschalis Gavriilidis, Theofilos Poutahidis, Alexander Giakoustidis, et al.
Pageof 1